{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:10:11Z","timestamp":1792131011496,"version":"4.4.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008758","name":"Council of Science and Technology, U.P.","doi-asserted-by":"publisher","award":["CST\/8307"],"award-info":[{"award-number":["CST\/8307"]}],"id":[{"id":"10.13039\/501100008758","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJOG Global Reports"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.xagr.2023.100177","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T03:34:09Z","timestamp":1675740849000},"page":"100177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Correlation of sFlt\/PlGF ratio with severity of preeclampsia in an Indian population"],"prefix":"10.1016","volume":"3","author":[{"given":"Namrata","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinita","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjoo","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xagr.2023.100177_bib0001","series-title":"Williams Obstetrics","author":"Cunningham","year":"2022"},{"key":"10.1016\/j.xagr.2023.100177_bib0002","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xagr.2023.100177_bib0003","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/1471-0528.17240","article-title":"Maternal race and pre-eclampsia: cohort study and systematic review with meta-analysis","volume":"129","author":"Arechvo","year":"2022","journal-title":"BJOG"},{"key":"10.1016\/j.xagr.2023.100177_bib0004","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/JME.JME_168_20","article-title":"Prevalence of hypertensive disorders of pregnancy in India: a systematic review and meta-analysis","volume":"2","author":"Dhinwa","year":"2021","journal-title":"J Med Evid"},{"key":"10.1016\/j.xagr.2023.100177_bib0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12884-018-1667-7","article-title":"Prevalence of hypertensive disorders of pregnancy in Ethiopia: a systemic review and meta-analysis","volume":"18","author":"Berhe","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.xagr.2023.100177_bib0006","unstructured":"World Health Organization. Health topics. Maternal health. Available at: http:\/\/www.who.int\/topics\/maternal_health\/en\/. Accessed Aug 19 2017."},{"key":"10.1016\/j.xagr.2023.100177_bib0007","unstructured":"Faculty of Medicine. The University of British Columbia PRE-EMT. fullPIERS. Available at: https:\/\/preempt.cfri.ca\/monitoring\/fullpiers. Accessed Sep 5, 2019."},{"key":"10.1016\/j.xagr.2023.100177_bib0008","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s13224-019-01277-5","article-title":"Pilot interventional study comparing fetomaternal outcomes of 150 mg versus 75 mg aspirin starting between 11 and 14 weeks of pregnancy in patients with high risk of preeclampsia: a Randomized Control Trial","volume":"70","author":"Kumar","year":"2020","journal-title":"J Obstet Gynaecol India"},{"key":"10.1016\/j.xagr.2023.100177_bib0009","series-title":"Diagnostic guidance DG23.PlGF-based testing to help diagnose suspected pre-eclampsia (Triage PlGF test, Elecsys immunoassay sFlt-1\/PlGF ratio, DELFIA Xpress PlGF 1-2-3 test, and BRAHMS sFlt-1 Kryptor\/BRAHMS PlGF plus Kryptor PE ratio)","year":"2016"},{"key":"10.1016\/j.xagr.2023.100177_bib0010","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1373\/clinchem.2011.169094","article-title":"The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia","volume":"58","author":"Hagmann","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.xagr.2023.100177_bib0011","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xagr.2023.100177_bib0012","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5468\/ogs.2020.63.3.270","article-title":"A study to compare maternal and perinatal outcome in early vs. late onset preeclampsia","volume":"63","author":"Wadhwani","year":"2020","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.xagr.2023.100177_bib0013","series-title":"Hypertension in pregnancy: diagnosis and management: guidance","year":"2019"},{"issue":"Suppl 1","key":"10.1016\/j.xagr.2023.100177_bib0014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.13763","article-title":"A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia","volume":"154","author":"Poon","year":"2021","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.xagr.2023.100177_bib0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/pd.2660","article-title":"Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11\u201313 weeks","volume":"31","author":"Akolekar","year":"2011","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.xagr.2023.100177_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.07.037","article-title":"The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients","volume":"206","author":"Verlohren","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2023.100177_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/202346","article-title":"An elevated maternal plasma soluble fms-like tyrosine kinase-1 to placental growth factor ratio at midtrimester is a useful predictor for preeclampsia","volume":"2013","author":"Hassan","year":"2013","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.xagr.2023.100177_bib0018","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/AOG.0000000000004149","article-title":"Biomarkers and the prediction of adverse outcomes in preeclampsia: a systematic review and meta-analysis","volume":"137","author":"Lim","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xagr.2023.100177_bib0019","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","article-title":"Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor)-ratio in the clinical routine: a real-world study","volume":"77","author":"Dr\u00f6ge","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.xagr.2023.100177_bib0020","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/jog.14815","article-title":"sFlt-1\/PlGF ratio as a predictive and prognostic marker for preeclampsia","volume":"47","author":"Jeon","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.xagr.2023.100177_bib0021","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.preghy.2020.07.007","article-title":"L, sFlt-1\/PlGF ratio for the prediction of delivery within 48 hours and adverse outcomes in expectantly managed early-onset preeclampsia","volume":"22","author":"Sim\u00f3n","year":"2020","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.xagr.2023.100177_bib0022","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/uog.21949","article-title":"sFlt-1\/PlGF ratio and timing of delivery in early-onset fetal growth restriction with antegrade umbilical artery flow","volume":"56","author":"Quezada","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.xagr.2023.100177_bib0023","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/uog.24851","article-title":"Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia","volume":"59","author":"Reddy","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.xagr.2023.100177_bib0024","article-title":"The feasibility of soluble fms-like tyrosine kinase-1 (sFLT-1) and placental growth factor (PlGF) ratio biomarker in predicting preeclampsia and adverse pregnancy outcomes among medium to high-risk mothers in Kuala Lumpur","volume":"17","author":"Aminuddin","year":"2022","journal-title":"Malaysia. PLOS ONE"}],"container-title":["AJOG Global Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577823000187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577823000187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:21:11Z","timestamp":1763000471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666577823000187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2666577823000187"],"URL":"https:\/\/doi.org\/10.1016\/j.xagr.2023.100177","relation":{},"ISSN":["2666-5778"],"issn-type":[{"value":"2666-5778","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation of sFlt\/PlGF ratio with severity of preeclampsia in an Indian population","name":"articletitle","label":"Article Title"},{"value":"AJOG Global Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xagr.2023.100177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100177"}}